Channel blocker treats asthma in the lab – Baylor College of Medicine News

Channel blocker treats asthma in the lab
Baylor College of Medicine News
Today, in a recent edition of the Journal of Biological Chemistry, Beeton has shown that the synthetic analog, known as ShK-186, can inhibit the function of allergen-specific T lymphocytes from patients with asthma and in a rat model. T lymphocytes (a

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.